Our CEO Jeremy Bender recently had the pleasure of joining Biotech2050 to reflect on the journey we’ve been on at Day One Biopharmaceuticals—from a bold vision to prioritize pediatric oncology, to launching our first FDA-approved medicine. Jeremy discussed what it’s been like stepping into the CEO role for the first time, and lessons around leadership, focus, and staying true to your mission.

Listen to hear more about how small biotechs can drive big impact and best practices for leading a resilient organization through uncertain times. Thank you to Rahul Chaturvedi for the thought-provoking conversation around growth and innovation.